These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1984890)

  • 21. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
    J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
    Schelbert HR
    Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between reverse redistribution on planar thallium scintigraphy and regional myocardial viability: a correlative PET study.
    Soufer R; Dey HM; Lawson AJ; Wackers FJ; Zaret BL
    J Nucl Med; 1995 Feb; 36(2):180-7. PubMed ID: 7830110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thallium-201 uptake in lung cancer.
    Chin BB; Zukerberg BW; Buchpiguel C; Alavi A
    J Nucl Med; 1995 Aug; 36(8):1514-9. PubMed ID: 7629600
    [No Abstract]   [Full Text] [Related]  

  • 27. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 29. Multi-modality imaging for assessment of myocardial viability?
    Reyes E
    Int J Cardiovasc Imaging; 2007 Dec; 23(6):767-70. PubMed ID: 17588163
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
    Soufer R; Dey HM; Ng CK; Zaret BL
    Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals.
    Bax JJ; Visser FC; van Lingen A; Groeneveld AB; Huitink JM; Teule GJ; Visser CA
    Eur J Nucl Med; 1995 Jan; 22(1):56-60. PubMed ID: 7698156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.
    Dilsizian V; Bacharach SL; Khin MM; Smith MF
    J Nucl Cardiol; 2001; 8(1):75-88. PubMed ID: 11182712
    [No Abstract]   [Full Text] [Related]  

  • 34. Nuclear imaging techniques for the assessment of myocardial viability.
    Jain D; Zaret BL
    Cardiol Clin; 1995 Feb; 13(1):43-57. PubMed ID: 7796431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased fluorine-18 deoxyglucose uptake after percutaneous transluminal coronary angioplasty in recently infarcted myocardium.
    Hashimoto T; Kambara H; Fudo T; Nohara R; Hayashi M; Takatsu Y; Tamaki N; Konishi J; Kawai C
    Am J Cardiol; 1989 Mar; 63(11):743-4. PubMed ID: 2522272
    [No Abstract]   [Full Text] [Related]  

  • 37. On FDG PET metabolic imaging to assess myocardial viability.
    Brunken RC; Go RT; MacIntyre WJ
    J Nucl Med; 2000 Apr; 41(4):25N. PubMed ID: 10768553
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET.
    Altehoefer C; vom Dahl J; Bares R; Stöcklin GL; Büll U
    J Nucl Med; 1995 Nov; 36(11):2056-9. PubMed ID: 7472598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of reversible myocardial tissue injury (stunning) after thrombolytic therapy using radioisotope imaging techniques.
    Parodi O
    J Nucl Biol Med (1991); 1991; 35(2):63-5. PubMed ID: 1834191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.